Michael Hinds - Concepedia

Author

Michael Hinds

The University of Texas MD Anderson Cancer Center

Also Known As

M Hinds, M. Hinds, Michael D. Hinds, Michael Hinds

Publications

740

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center The University of Texas at Austin

About

Michael Hinds is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	415
2	Natural Sciences	4	4	182
3	Cell Biology	3	3	223
4	Health Sciences	1	1	10
5	Biomolecular Engineering	1	1	24

Michael Hinds

Publications

703

Citations

H-Index

Page 1

	Year	Citations
Characterization of an Amsacrine-resistant Line of Human Leukemia Cells Leonard A. Zwelling, Michael Hinds, Diana Chan, Journal of Biological Chemistry	1989	179
Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Michael Hinds, Karl Deisseroth, Janice Mayes, PubMed Mixed-phenotype Acute LeukemiaGeneticsMolecular BiologyHl-60/amsa LineTumor Biology	1991	152
Properties of R1162, a broad-host-range, high-copy-number plasmid R J Meyer, Michael Hinds, Michael A. Brasch Journal of Bacteriology High-copy-number PlasmidGeneticsMolecular BiologyMolecular GeneticsSequence Design	1982	65
HT1080/DR4: A P-Glycoprotein-Negative Human Fibrosarcoma Cell Line Exhibiting Resistance to Topoisomerase II-Reactive Drugs Despite the Presence of a Drug-Sensitive Topoisomerase II Leonard A. Zwelling, Marilyn L. Slovak, J. H. Doroshow, JNCI Journal of the National Cancer Institute	1990	58
Multiple mechanisms for expression of incompatibility by broad-host-range plasmid RK2 R J Meyer, Michael Hinds Journal of Bacteriology Genome InstabilityMultiple MechanismsGeneticsNatural SciencesGenomic Mechanism	1982	48
Broad-host-range IncP-4 plasmid R1162: effects of deletions and insertions on plasmid maintenance and host range R J Meyer, Reneé A. Laux, Gary Boch, Journal of Bacteriology Host RangePseudomonas StrainsPlasmid MaintenanceNatural SciencesGenetics	1982	45
Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions Leonard A. Zwelling, Janice Mayes, Michael Hinds, Biochemistry	1991	38
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation. Leonard A. Zwelling, Michael Hinds, Diana Chan, PubMed Chemoprevention StrategyMixed-phenotype Acute LeukemiaEtoposide-induced Dna CleavageTumor BiologyDna Cleavage	1990	36
Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Leonard A. Zwelling, Diana Chan, Michael Hinds, PubMed Etoposide-induced Dna CleavageHuman Leukemia CellsCancer BiologyTumor BiologyEtoposide-mediated Dna Cleavage	1988	35
Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development. L A Zwelling, Michael Mitchell, Patricia Satitpunwaycha, PubMed Chemoprevention StrategyAmsacrine ResistanceChemical BiologyRelative ActivityPharmaceutical Chemistry	1992	24

Page 1